Previously: Congenital disorder of glycosylation, type 1q (CDG1Q)
Generalized scaling with PPK; hypertrichosis; eye issues; developmental delay.
Dry skin with variable eczematous dermatitis; PPK; hyperpigmentation over knees and acral sites; sometimes hypertrichosis.
Dysmorphic facies; colobomata, hypertelorism, nystagmus, optic disc hypoplasia, variable visual loss; delayed intellectual and motor development, brain anomalies; pituitary gland hypoplasia; microcytic anaemia, coagulation defects, antithrombin III deficiency.
Kamarus Jaman N, Rehsi P, Henderson RH et al. SRD5A3-CDG: emerging phenotypic features of an ultrarare CDG subtype. Front Genet 2021; 12:737094.
Summarised from published literature for general information. This is not medical advice, and entries are still being verified. Read the full disclaimer
This feature is coming soon.
This is a reference resource for clinicians and researchers. It is not medical advice or a diagnostic tool.
The database is still being verified and entries may be incomplete. Do not rely on it without independent professional judgement.
If you are a patient, parent or carer, please speak to your doctor about any symptoms or concerns.